Endoscopy 2024; 56(S 02): S362-S363
DOI: 10.1055/s-0044-1783590
Abstracts | ESGE Days 2024
ePoster

Initial results of screening program in Mongolia where burdening high gastric cancer – Multi center study

B. Jargalsaikhan
1   Mongolian National University, Ulaanbaatar, Mongolia
,
G. Boldbaatar
2   Mongolian National University of Medical Sciences , Ulaanbaatar, Mongolia
,
T. Khurelbaatar
3   Mongolian Japanese Teaching Hospital, MNUMS, Ulaanbaatar, Mongolia
,
S. Tserenchimed
4   Intermed Hospital, Ulaanbaatar, Mongolia
,
D. Jambal
5   Bayanhongor General hospital, Bayankhongor, Mongolia
,
B. Bayaraa
6   Songinokhairkhan district Health center, Ulaanbaatar, Mongolia
,
G. Baatar
7   Shinonmed hospital, Uvurkhangai, Mongolia
,
R. Sadel
8   Citymed hospital, Ulaanbaatar, Mongolia
,
C. Tsolmonbaatar
9   Baganuur Hospital, Baganuur, Mongolia
,
S. Purevsuren
10   Nomun Clinic Hospital, Ulaanbaatar, Mongolia
,
D. Monkhjargal
11   Uvurkhangai Hospital, Arvaikheer, Mongolia
,
B. Altankhuyag
12   Dornod Regional Diagnosis and Treatment Center , Choibalsan, Mongolia
,
E. Batkhuyag
13   Khovd General hospital, Khovd, Mongolia
,
B. Barkhas
14   General hospital for State special servants, Ulaanbaatar, Mongolia
,
O. Damdinsuren
15   Sukhbaatar General hospital, Sukhbaatar, Mongolia
,
T. Tolya
16   The First Central Hospital, Ulaanbaatar, Mongolia
› Author Affiliations
› Further Information
Also available at
 

Aims Background: Mongolia is the leading country by the incidence and mortality rate of gastric. In 2022 national cancer screening program for upper gastrointestinal neoplasia was initiated therefore we conducted the multi-center study for determining the gastric cancer among Mongolian population.

Methods Methods: The cross sectional study was performed to screen the precancerous lesion (LGD, Atypia) and cancerous lesion (HGD, adenocarcinoma, signet cell carcinoma etc.) assessed among the people who underwent gastric endoscopy in 28 endoscopy centers in Mongolia during from May of 2022 to September of 2022. (Endoscopic centers of Ulaanbaatar city's 9 district and 21 provinces). The primary outcomes of this study was to define detection rate (proportion of positive cases among individuals who underwent endoscopic screening) and to determine the characteristics of cancer type including its precursor disease.

Results Results: Totally 34,581 people were screened from May 2022 to September 2022. Among them n=262 (0.8%) patients diagnosed with gastric cancer based on endoscopic examination. The proportion of early stage gastric cancer was n=135 (51.5%) of all screened cancer cases.

Conclusions Conclusion: The initiation of Mongolian national gastric cancer screening program was useful to detect gastric cancer in early stage which further can reduce mortality rate of gastric cancer due to its treatment possibilities. Therefore, national screening program should be continuous. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24]



Publication History

Article published online:
15 April 2024

© 2024. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Morgan E., Arnold M., Camargo M.Constanza, Gini A., Kunzmann A.T., Matsuda T., Meheus F., Verhoeven R.H.A., Er Ome Vignat J., Laversanne M., Ferlay J., Soerjomataram I.. (n.d.) The current and future incidence and mortality of gastric cancer in 185 countries, 2020−40: A population-based modelling study. DOI: 10.1016/j.
    CrossrefPubMedGoogle Scholar
  • 2 Arnold M., Park J.Y., Camargo M.C., Lunet N., Forman D., Soerjomataram I.. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut 2020; 69 (05) 823-829 DOI: 10.1136/gutjnl-2019-320234.
    CrossrefPubMedGoogle Scholar
  • 3 Choi K.S., Jun J.K., Lee H.Y., Park S., Jung K.W., Han M.A., Choi I.J., Park E.C.. Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea. Cancer Science 2011; 102 (08) 1559-1564 DOI: 10.1111/j.1349-7006.2011.01982.x.
    CrossrefPubMedGoogle Scholar
  • 4 Hosokawa O., Shimbo T., Matsuda K., Miyanaga T.. Impact of opportunistic endoscopic screening on the decrease of mortality from gastric cancer. Gastric Cancer 2011; 49: 401-407
    PubMedGoogle Scholar
  • 5 Hamashima C., Fukao A., Hosokawa O., Ichinose M., Narisawa R., Saito H., Shibuya D., Yoshino J.. Quality assurance manual of endoscopic screening for gastric cancer in Japanese communities. Japanese Journal of Clinical Oncology 2016; 46 (11) 1053-1061 https10.1093/jjco/hyw106
    CrossrefPubMedGoogle Scholar
  • 6 Sugano K.. Screening of gastric cancer in Asia. Best Practice & Research Clinical Gastroenterology 2015; 29 (06) 895-905 DOI: 10.1016/J.BPG.2015.09.013.
    CrossrefPubMedGoogle Scholar
  • 7 Lee S., Jun J.K., Suh M., Park B., Noh D.K., Jung K.W., Choi K.S.. Gastric cancer screening uptake trends in Korea: Results for the national cancer screening program from 2002 to 2011. Medicine (United States) 2015; 94 (08) e533 DOI: 10.1097/MD.0000000000000533.
    CrossrefPubMedGoogle Scholar
  • 8 Nakamura Y., Takeshita M., Hirota Y., Ueda K., Yao T., Kohzuki T., Omae T., Yoshimura T.. An evaluation of gastric cancer screening program in Hisayana, Japan. Gastroenterologia Japonica 1977; 12 (06) 427-434 DOI: 10.1007/BF02781334.
    CrossrefPubMedGoogle Scholar
  • 9 Yashima K., Shabana M., Kurumi H., Kawaguchi K., Isomoto H.. Gastric Cancer Screening in Japan: A Narrative Review. In Journal of Clinical Medicine 2022; Vol. 11 (Issue 15): MDPI. DOI: 10.3390/jcm11154337
    CrossrefPubMedGoogle Scholar
  • 10 Hamashima C., Kato K., Miyashiro I., Nishida H., Takaku R., Terasawa T., Yoshikawa T., Honjo S., Inoue K., Nakayama T., Nakayama T., Narisawa R., Sagawa M., Saito H., Shibuya D., Sobue T.. Update version of the Japanese guidelines for gastric cancer screening. Japanese Journal of Clinical Oncology 2018; 48 (07) 673-683 DOI: 10.1093/jjco/hyy077.
    CrossrefPubMedGoogle Scholar
  • 11 Kim B., Cho S.J.. Endoscopic Screening and Surveillance for Gastric Cancer. In Gastrointestinal Endoscopy Clinics of North America. 2021. Vol. 31 (Issue 3): pp 489-501 W.B. Saunders; DOI: 10.1016/j.giec.2021.03.004
    CrossrefGoogle Scholar
  • 12 Mabe K., Inoue K., Kamada T., Kato K., Kato M., Haruma K.. Endoscopic screening for gastric cancer in Japan: Current status and future perspectives. In Digestive Endoscopy. 2022: Vol. 34 (Issue 3): pp 412–419 John Wiley and Sons Inc;. doi:10.1111/den.14063
    PubMedGoogle Scholar
  • 13 Lu Y.F., Liu Z.C., Li Z.H., Ma W.H., Wang F.R., Zhang Y.B., Lu J.B.. Esophageal/gastric cancer screening in high-risk populations in Henan Province, China. Asian Pacific Journal of Cancer Prevention 2014; 15 (03) 1419-1422 DOI: 10.7314/APJCP.2014.15.3.1419.
    CrossrefPubMedGoogle Scholar
  • 14 Zeng H., Sun K., Cao M., Zheng R., Sun X., Liu S., Zhang Z., Liu Y., Guo G., Song G., Zhu Y., Wu X., Song B., Liao X., Chen Y., Song M., Giovannucci E., Zhuang G., Wei W., He J.. Initial results from a multi-center population-based cluster randomized trial of esophageal and gastric cancer screening in China. BMC Gastroenterology 2020; 20 (1):. doi:10.1186/s12876-020-01517-3
    PubMedGoogle Scholar
  • 15 Khasag O., Boldbaatar G., Tegshee T., Duger D., Dashdorj A., Uchida T., Matsuhisa T., Yamaoka Y.. The prevalence of Helicobacter pylori infection and other risk factors among Mongolian dyspeptic patients who have a high incidence and mortality rate of gastric cancer. Gut Pathogens 2018; 10 (1):. doi:10.1186/s13099-018-0240-2
    PubMedGoogle Scholar
  • 16 Yang X., Zhang T., Zhang H., Sang S., Chen H., Zuo X.. Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia. Biomarker Research 2021; 9 (1):. doi:10.1186/s40364-021-00340-6
    PubMedGoogle Scholar
  • 17 Sambuu T., Tumurbat N., Davaa B., Tudev B.-E.. Incidence of Stomach and Esophageal Cancers in Mongolia: Data from 2009 to 2018. Euroasian Journal of Hepato-Gastroenterology 2020; 10 (01) 16-21 DOI: 10.5005/jp-journals-10018-1313.
    CrossrefPubMedGoogle Scholar
  • 18 Sandagdorj T., Sanjaajamts E., Tudev U.. Cancer Incidence and Mortality in Mongolia – National Registry Data. Asian Pacific Journal of Cancer Prevention 2010; 11 (06) 1509-1514 http://journal.waocp.org/article_25406.html
    PubMedGoogle Scholar
  • 19 Chimed T., Sandagdorj T., Znaor A., Laversanne M., Tseveen B., Genden P., Bray F.. Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008–12. International Journal of Cancer 2017; 140 (02) 302-309 DOI: 10.1002/ijc.30463.
    CrossrefPubMedGoogle Scholar
  • 20 Karimi P., Islami F., Anandasabapathy S., Freedman N.D., Kamangar F.. Gastric cancer: Descriptive epidemiology, risk factors, screening, and prevention. In Cancer Epidemiology Biomarkers and Prevention. 2014:. doi:( Vol. 23 (Issue 5):. doi:pp. 700–713 American Association for Cancer Research Inc.;. doi:10.1158/1055-9965.EPI-13-1057
    PubMedGoogle Scholar
  • 21 Ning F.L., Lyu J., Pei J.P., Gu W.J., Zhang N.N., Cao S.Y., Zeng Y.J., Abe M., Nishiyama K., Zhang C.D.. The burden and trend of gastric cancer and possible risk factors in five Asian countries from 1990 to 2019. Scientific Reports 2022; 12 (1):. doi:10.1038/s41598-022-10014-4
    PubMedGoogle Scholar
  • 22 Sitarz R., Skierucha M., Mielko J., Offerhaus G.J.A., Maciejewski R., Polkowski W.P.. Gastric cancer: Epidemiology, prevention, classification, and treatment. In Cancer Management and Research. 2018: Vol. 10: pp. 239–248 Dove Medical Press Ltd.;. doi:10.2147/CMAR.S149619
    PubMedGoogle Scholar
  • 23 Rawla P., Barsouk A.. Epidemiology of gastric cancer: Global trends, risk factors and prevention. In Przeglad Gastroenterologiczny. 2019: Vol. 14 (Issue 1): pp 26–38 Termedia Publishing House Ltd.;. doi:10.5114/ pg.2018.80001
    PubMedGoogle Scholar
  • 24 Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F.. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians 2021; 71 (03) 209-249 DOI: 10.3322/caac.21660.
    CrossrefPubMedGoogle Scholar